Wednesday, October 18, 2006


On October 6th I told readers to look into Johnson & Johnson (JNJ). Today JNJ hit another 52-week high. Readers could have made a quick 4.7%. For the risk averse, Nabi Biopharma (NABI) is up 14% since I mentioned it and NeoPharm (NEOL) is up a HEFTY 41%. Nice work Big Ben! I wish I had followed my own advice.


Blogger Md said...

I wish I would have bought some too.

10/19/2006 6:10 PM  
Blogger Big Ben said...

Especially NEOL. Although after doing some more research on NEOL; the company has cut R&D and put all of its eggs into one drug. NEOL still has some nice insider buying.

10/20/2006 10:51 PM  

Post a Comment

<< Home